arrow
Y

Yasumasa Kakei

Kobe University Graduate School of Medicine
H指数:15
被引数:906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Four-year neurodevelopmental outcomes in infants with symptomatic congenital cytomegalovirus disease treated with oral valganciclovir: A prospective follow-up study in Japan

口服缬更昔洛韦治疗有症状先天性巨细胞病毒疾病的婴儿的四年神经发育结局:一项日本前瞻性随访研究

2026-06-010
PRE
Three-year hearing outcomes in infants with congenital cytomegalovirus disease treated with oral valganciclovir: Interim results of a six-year follow-up study in Japan

口服缬更昔洛韦治疗先天性巨细胞病毒疾病婴儿的三年听力结果: 日本六年随访研究的中期结果

2025-03-010
PRE
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial

口腔癌疫苗B440在PD-1/PD-L1抑制剂耐药的晚期尿路上皮癌患者中的安全性和有效性: 1期多中心,开放标签,单臂临床试验的研究方案

2025-02-040
OAAI
Effect and safety of ethanolamine oleate in sclerotherapy in patients with difficult-to-resect venous malformations: A multicenter, single-arm study

乙氧硬化醇在难治性静脉畸形硬化治疗中的疗效与安全性:一项多中心、单臂研究

2025-01-310
OA
Post-Hoc Analysis of a Multicenter Clinical Trial: Correlation of Coagulation Factor Changes and MRI-Defined Treatment Outcomes After Sclerotherapy for Venous Malformations
2025-01-300
OAAI
Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study
2024-09-160
OAAI
Oral Valganciclovir Therapy in Infants Aged ≤2 Months with Congenital Cytomegalovirus Disease: A Multicenter, Single-Arm, Open-Label Clinical Trial in Japan

在患有先天性巨细胞病毒疾病的 ≤ 2个月婴儿中口服缬更昔洛韦治疗: 日本的一项多中心,单臂,开放标签临床试验

2022-06-2121
OAAI
Open-label multicenter registry on the outcomes of peripheral arterial disease treated by balloon angioplasty with optical frequency domain imaging in superficial femoral artery and popliteal artery (OCEAN-SFA study)
2020-06-295
PREAI